<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The two modes of self-destruction at the cellular level - <z:mpath ids='MPATH_3'>apoptosis</z:mpath> (self-killing) and autophagy (self-eating) - are thought to be <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressive </plain></SENT>
<SENT sid="1" pm="."><plain>In particular, germline loss of function of genes involved in autophagy has been associated with <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>However, recent studies, including the one by Maclean et al. reported in this issue of the JCI, indicate that autophagy can provide a means for cell survival when nutrients are limiting, such that inhibition of autophagy by the <z:chebi fb="1" ids="38068">antimalarial</z:chebi> drug <z:chebi fb="3" ids="3638">chloroquine</z:chebi> can inhibit <z:mp ids='MP_0002006'>tumorigenesis</z:mp>, specifically Myc-induced <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in mice (see the related article beginning on page 79) </plain></SENT>
<SENT sid="3" pm="."><plain>These findings suggest that a new use of an old drug for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention may profoundly affect disease outcome </plain></SENT>
</text></document>